下載

D-U-N-S® Certified Profile

Issued Date: 2020/11/12
Validity Date: 2025/11/11
Business Basic Informationcheckbox imgVerified by D&B
D-U-N-S® Number 65-883-9224
Business Registration No. 42932624
Company Name Fecula Biotech Co., Ltd.
Company Type a private company limited by shares
Company Operating Address Rm. 405, No. 12, Nanke 2nd Rd., Xinshi Dist., Tainan City, Taiwan
Phone
+886-6-5050511
Fax
+886-6-2116924
Email Contact Us
Company Website www.fecula.com.tw
Taiwantrade Website of Company fecula.en.taiwantrade.com/
Line of Business Wholesale of Other Food | microbiome-based dietary supplements development;Microbiome based cancer adjuvant therapy.
Main Products Gene-Young Pre-Post-Probiotics capsules
Ca2+-Care chewable tablets
Love Living Tablets
Hepatickey capsules
De-Stress capsules
Oral cancer vaccine
Brand Name Gene-Young vegan probiotics capsules
Ca2+-Care chewable tablets
Love Living Tablets
Fecula Biotech Co., Ltd.
Hepatickey capsules
De-Stress capsules
SIC Code
51410000, 51490602
Employee Here 1~9
Employee Total 1~9
About Companycheckbox imgProvided by Customer
Fecula Biotech Co., Ltd. was established in February 2019. Issued capital is NTD 35 million, one of shareholder is National Development Fund Startup Angel Project. The Headquarter is located in the SME incubator at Tainan Science Park. Our mission is to generate innovative efficient approaches to convert growing agricultural waste issues into eco-efficient eco-based products opportunities with direct benefits for both environment, economy and consumer. We have successfully transformed the agro-waste such as banana, Citrus depressa Hayata, strawberry leaf and fish scale into functional food ingredient and supplement products as well. Furthermore, the strawberry leaf extract has been successfully developed as cosmetics ingredient and the clinical studies indicated that the strawberry leaf extracts exhibited visible improvements in skin brightness, moisture, and elasticity. Our core technology is a Resistant Starch-Based Encapsulation Technique (RS-BET) using banana resistant starch as building block. Based on different specification of resistant starch, the RS-BET is appliable to pharmaceutical and supplements development. By combining the strength of probiotics and new agricultural resources, the microbiota-related (probiotic) dietary supplements were launched and market products all over the world. Currently, our supplement products are sold in the United State and Mainland China by e-commerce, in the Vietnam by TV shopping, and in Taiwan by pharmacy chain stores of Great Tree Pharmacy Co., Ltd. We are also developing microbiome-based therapeutics and vaccine using core technology of RS-BET. The pipeline includes (1) Oral delivery of HCC vaccine; (2) oral FMT capsule for cancer adjuvant therapy; (3) Botanical drug for the inhibition of cancer invasion and metastasis. We will continue to devote our efforts to convert agricultural waste into value-added bioproducts and supports the goal of sustainable development in circular economy.
Business Registration Informationcheckbox imgVerified by D&B
Registration Date 2019/02/26
Authorized Capital TWD 35,000,000
Paid Up Capital TWD 35,000,000
Registration Address Room R405, No. 12, Nanke 2nd Rd., Xinshi Dist., Tainan City
Name of Representative Chen, Zhi Ming
Registraction Authority
Management Informationcheckbox imgVerified by D&B
Name Jobtitle On board date
Chen, Chih-Ming President 02/16/2019
Trading Capabilitycheckbox imgVerified by D&B
No. of Foreign Trading Staff
Bureau of Foreign Trade Information
Import Qualification YES
Export Qualification YES
Actual Import/ Export Value Range
Year Range Import Volumn (USD) Export Volumn (USD)
2024 0 0~500,000
2023 0 0
2022 0 0~500,000
2021 0 0
2020 0 0
2019 0 0
R&D Capability and Production Capabilitycheckbox imgProvided by Customer
No. of R&D staff 4
R&D Expense to Revenue Ratio in the Most Recent Years 50.00%